Jordan - Re-Export of Heparin for Therapeutic Use
Since 2014, Jordan Re-Export of Heparin for Therapeutic Use fell by 22.7% year on year. In 2019, the country was ranked number 5 among other countries in Re-Export of Heparin for Therapeutic Use at $114,511.44. Jordan is overtaken by Saudi Arabia, which was number 4 with $173,620.88 and is followed by New Zealand at $90,204.13. United States lead the ranking with $4,598,060.57 in 2019, that is -5.2% versus 2018. New Zealand recorded the best 5 years average growth at +141.8% per year, while United States witnessed the worst performance at -29.7% per year.
| Date | US Dollars |
|---|---|
| 2019 | 114,511.44 |
| 2018 | 122,191.58 |
| 2017 | 80,978.89 |
| 2016 | 134,141.00 |
| 2015 |
Download all data from 1999 to 2019
How does Jordan rank in Re-Export of Heparin for Therapeutic Use?
| # | 10 Countries | US Dollars | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
United States
|
4,598,060.57 | 2019 | -5.2 % | -29.7 % | View data | |
| 2 |
#2
Canada
|
728,579.06 | 2019 | +2.9 % | +13.3 % | View data | |
| 4 |
#4
Saudi Arabia
|
173,620.88 | 2016 | -45.1 % | NA | View data | |
| 5 |
#5
Jordan
|
114,511.44 | 2019 | -6.3 % | -22.7 % | View data | |
| 6 |
#6
New Zealand
|
90,204.13 | 2019 | -3.7 % | +141.8 % | View data | |